-
1
-
-
0028183017
-
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)
-
Hoyer D, Clarke DE, Fozard JR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP: International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). PharmacolRev(1994) 46:157-203.
-
(1994)
PharmacolRev
, vol.46
, pp. 157-203
-
-
Hoyer, D.1
Clarke, D.E.2
Fozard, J.R.3
Martin, G.R.4
Mylecharane, E.J.5
Saxena, P.R.6
Humphrey, P.P.7
-
2
-
-
0032970989
-
A review of central 5-HT receptors and their function
-
Bames NM, Sharp T: A review of central 5-HT receptors and their function. Neuropharmacology (1999) 38:1083-1152. This is an excellent review of the various serotanin receptor subtypes, highlighting their distribution and functional significance of each subtype reported to date.
-
(1999)
Neuropharmacology
, vol.38
, pp. 1083-1152
-
-
Bames, N.M.1
Sharp, T.2
-
3
-
-
0025193322
-
The serotonin 5-HT,D receptor: A progress review
-
Waeber C, Schoeffer P, Hoyer D, Palacios JM: The serotonin 5-HT,D receptor: a progress review. Neurochem Res (1990) 15:573-588.
-
(1990)
Neurochem Res
, vol.15
, pp. 573-588
-
-
Waeber, C.1
Schoeffer, P.2
Hoyer, D.3
Palacios, J.M.4
-
4
-
-
0024538938
-
Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain
-
Hoyer D, Middlemiss DN: Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends PharmacolSci(1989) 10:130-132.
-
(1989)
Trends PharmacolSci
, vol.10
, pp. 130-132
-
-
Hoyer, D.1
Middlemiss, D.N.2
-
7
-
-
0034157403
-
-
Millson DS, Tepper SJ, Rapoport AM: Migraine pharmacotherapy with oral triptans: a rational approach to clinical management Exp Opin Pharmacother(2000) 1(3):391-404. An excellent review of the pharmacodynamic (5-HTw agonism) and pharmacokinetic properties of currently marketed triptans which correlates these properties to their clinical efficacy in the management of migraine.
-
(2000)
Exp Opin Pharmacother
, vol.1
, Issue.3
, pp. 391-404
-
-
-
8
-
-
0034157403
-
Migraine pharmacotherapy with oral triptans a rational approach to clinical management
-
Millson DS, Tepper SJ, Rapoport AM: Migraine pharmacotherapy with oral triptans: a rational approach to clinical management Exp Opin Pharmacother(2000) 1(3):391-404. An excellent review of the pharmacodynamic (5-HTw agonism) and pharmacokinetic properties of currently marketed triptans which correlates these properties to their clinical efficacy in the management of migraine.
-
(2000)
Exp Opin Pharmacother
, vol.1
, Issue.3
, pp. 391-404
-
-
Millson, D.S.1
Tepper, S.J.2
Rapoport, A.M.3
-
9
-
-
0031771420
-
1B/1D receptor agonists in migraine
-
1B/1D receptor agonists in migraine. CNS Drugs (1989) 10:271 -286.
-
(1989)
CNS Drugs
, vol.10
, pp. 271-286
-
-
Goadsby, P.J.1
-
10
-
-
0030914002
-
Rizatriptan has central antinociceptive effects against durally evoked responses
-
Cumberbatch MJ, Hill R, Hargreaves RJ: Rizatriptan has central antinociceptive effects against durally evoked responses. Eur J Pharmacol(1997) 328:37-40.
-
(1997)
Eur J Pharmacol
, vol.328
, pp. 37-40
-
-
Cumberbatch, M.J.1
Hill, R.2
Hargreaves, R.J.3
-
11
-
-
0027509161
-
The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in human and cats
-
Goadsby PJ, Edvinsson L: The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in human and cats. Ann Weura(1993) 33:48-56.
-
(1993)
Ann Weura
, vol.33
, pp. 48-56
-
-
Goadsby, P.J.1
Edvinsson, L.2
-
12
-
-
0030902898
-
The novel antimigraine agent rizatriptan inhibits neurogenic durai vasodiiation and extravasation
-
Williamson DJ, Shepheard SL, Hill RG, Hargreaves RJ: The novel antimigraine agent rizatriptan inhibits neurogenic durai vasodiiation and extravasation. EurJ Pharmacol (1997) 328:61 -64.
-
(1997)
EurJ Pharmacol
, vol.328
, pp. 61-64
-
-
Williamson, D.J.1
Shepheard, S.L.2
Hill, R.G.3
Hargreaves, R.J.4
-
13
-
-
0030977313
-
Sumatriptan inhibits neurogenic vasodilation of durai blood vessels in the anaesthetized rat - Intravital microscope studies
-
Wilüamson DJ, Hargreaves RJ, Hill RG, Shepheard SL: Sumatriptan inhibits neurogenic vasodilation of durai blood vessels in the anaesthetized rat - Intravital microscope studies. Cephalagia (1997) 17:525-531.
-
(1997)
Cephalagia
, vol.17
, pp. 525-531
-
-
Wilüamson, D.J.1
Hargreaves, R.J.2
Hill, R.G.3
Shepheard, S.L.4
-
14
-
-
0027223875
-
Expression of mRNA for the serotonin 5-hydroxytryptamine 1D receptor subtype in human and bovine cerebral arteries
-
Hamel E, Fan E, LJnvilie D, Ting V, Villemure JG, Chia LS: Expression of mRNA for the serotonin 5-hydroxytryptamine 1D receptor subtype in human and bovine cerebral arteries. Mol Pharmacol (1993)44242-246.
-
(1993)
Mol Pharmacol
, pp. 44242-44246
-
-
Hamel, E.1
Fan, E.2
Ljnvilie, D.3
Ting, V.4
Villemure, J.G.5
Chia, L.S.6
-
15
-
-
0028175755
-
Selective 5-HT,0 ' serotonin receptor gene expression in trkjeminal ganglia: Implications for antimigraine drug development
-
Rebeck GW, Maynard Kl, Hyman BT, Moskowitz MA: Selective 5-HT,0 ' serotonin receptor gene expression in trkjeminal ganglia: implications for antimigraine drug development. Proc NatlAcad Sei USA (1994) 91:3666-3669.
-
(1994)
Proc NatlAcad Sei USA
, vol.91
, pp. 3666-3669
-
-
Rebeck, G.W.1
Maynard, K.I.2
Hyman, B.T.3
Moskowitz, M.A.4
-
16
-
-
0029813854
-
Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels
-
Bouchelet I, Cohen Z, Case B, Seguela P, Hamel : Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol (1996) 50:219-223.
-
(1996)
Mol Pharmacol
, vol.50
, pp. 219-223
-
-
Bouchelet, I.1
Cohen, Z.2
Case, B.3
Seguela, P.4
Hamel5
-
17
-
-
0031283073
-
Differential distribution of 5HT,immunoreactivity within the human trigemino-cerebrovascular system Implications for the discovery of new antimigraine drugs
-
Longmore J, Shaw D, Smith D, Hopkins R, McAIster G, Pickard JD, Sirinathsinghji DRD, Butler AJ, Hill R: Differential distribution of 5HT,immunoreactivity within the human trigemino-cerebrovascular system: Implications for the discovery of new antimigraine drugs. Cephalagia (1997)17:833-842.
-
(1997)
Cephalagia
, pp. 17833-17842
-
-
Longmore, J.1
Shaw, D.2
Smith, D.3
Hopkins, R.4
McAister, G.5
Pickard, J.D.6
Sirinathsinghji, D.R.D.7
Butler, A.J.8
Hill, R.9
-
18
-
-
0028816276
-
Cardiovascular adverse reactions to sumatriptan. Cause for Concern?
-
Ottervanger JP, Stricker BH: Cardiovascular adverse reactions to sumatriptan. Cause for Concern? CNS Drugs (1995) 3:90-98.
-
(1995)
CNS Drugs
, vol.3
, pp. 90-98
-
-
Ottervanger, J.P.1
Stricker, B.H.2
-
19
-
-
0032780399
-
Structure-activity relationships and pharmacological profiles of new 5-HT, receptor agonists as antimigraine agents
-
Perez M, John GW: Structure-activity relationships and pharmacological profiles of new 5-HT, receptor agonists as antimigraine agents. CurrOpin Drug Discovery Dev(1999) 2:304-310. A concise but comprehensive review highlighting the pharmacological properties of recently developed 5-HT,a agonists (both selective and nonselective) with particular emphasis on a class of non-selective ligands showing some degree of tissue selectivity.
-
(1999)
CurrOpin Drug Discovery Dev
, vol.2
, pp. 304-310
-
-
Perez, M.1
John, G.W.2
-
20
-
-
0032897777
-
Recent developments in 5-HT1D agonists
-
Russell MGN: Recent developments in 5-HT1D agonists. IDrugs (1999)2:37-43.
-
(1999)
IDrugs
, vol.2
, pp. 37-43
-
-
Russell, M.G.N.1
-
22
-
-
0030669050
-
-
MacLeod AM, Street LJ, Reeve AJ, Jelly RA, Stemfeld F, Beer MS, Stanton JA, Watt AP, Rathbone D, Matassa VG: Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents. J Med Chem (1997) 40:3501 -3503.
-
(1997)
J Med Chem
, vol.40
, pp. 3501-3503
-
-
-
23
-
-
0030669050
-
Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents
-
MacLeod AM, Street LJ, Reeve AJ, Jelly RA, Stemfeld F, Beer MS, Stanton JA, Watt AP, Rathbone D, Matassa VG: Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents. J Med Chem (1997) 40:3501 -3503.
-
(1997)
J Med Chem
, vol.40
, pp. 3501-3503
-
-
MacLeod, A.M.1
Street, L.J.2
Reeve, A.J.3
Jelly, R.A.4
Stemfeld, F.5
Beer, M.S.6
Stanton, J.A.7
Watt, A.P.8
Rathbone, D.9
Matassa, V.G.10
-
24
-
-
0031857819
-
Enhancement of oral absorption in selective 5-HT, receptor agonists: Fluorinated 3-[3-{piperidin-1-ylpropyl]indoles
-
Castro JL, Collins I, Russell GNM, Watt AP, Sohal B, Rathbone D, Beer MS, Stanton JA: Enhancement of oral absorption in selective 5-HT, receptor agonists: fluorinated 3-[3-{piperidin-1-yl)propyl]indoles. J Med Chem (1998) 41:2667-2670.
-
(1998)
J Med Chem
, vol.41
, pp. 2667-2670
-
-
Castro, J.L.1
Collins, I.2
Gnm, R.3
Watt, A.P.4
Sohal, B.5
Rathbone, D.6
Beer, M.S.7
Stanton, J.A.8
-
25
-
-
0033518190
-
3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT,D receptor agonists
-
Russell GNM, Matassa GV, Pengilley RR, Van Niel BM, Sohal B, Watt PA, Hitzel L, Beer SM, Stanton A J, Broughton BH, Castro LJ: 3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT,D receptor agonists. J Med Chem (1999) 42:4981-5001.
-
(1999)
J Med Chem
, vol.42
, pp. 4981-5001
-
-
Gnm, R.1
Matassa, G.V.2
Pengilley, R.R.3
Van Niel, B.M.4
Sohal, B.5
Watt, P.A.6
Hitzel, L.7
Beer, S.M.8
Stanton, A.J.9
Broughton, B.H.10
Castro, L.J.11
-
26
-
-
0033530881
-
-
Bourrain S, Neduvelil JG, Beer MS, Stanton JA, Showll GA, MacLeod AM: 4-Hydroxy-1-{3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyr| piperidines: selective h5-HTc agonists for the treatment of migraine. Bioorg Med Chem Lett (1999) 9:3369-3374.
-
(1999)
Bioorg Med Chem Lett
, vol.9
, pp. 3369-3374
-
-
-
27
-
-
0033530881
-
4-Hydroxy-1-{3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyr| piperidines: Selective h5-HTc agonists for the treatment of migraine
-
Bourrain S, Neduvelil JG, Beer MS, Stanton JA, Showll GA, MacLeod AM: 4-Hydroxy-1-{3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyr| piperidines: selective h5-HTc agonists for the treatment of migraine. Bioorg Med Chem Lett (1999) 9:3369-3374.
-
(1999)
Bioorg Med Chem Lett
, vol.9
, pp. 3369-3374
-
-
Bourrain, S.1
Neduvelil, J.G.2
Beer, M.S.3
Stanton, J.A.4
Showll, G.A.5
MacLeod, A.M.6
-
29
-
-
0034618184
-
1D receptor agonists
-
1D receptor agonists. Bioorg Med Chem Lett (2000) 10:1707-1709.
-
(2000)
Bioorg Med Chem Lett
, vol.10
, pp. 1707-1709
-
-
Slassi, A.1
Edwards, L.2
O'Brien, A.3
Meng, Q.C.4
Xin, T.5
Seto, C.6
Rakhit, S.7
Dkh, L.8
MacLean, N.9
Hynd, D.10
Chen, C.11
Wang, H.12
Kamboj, R.13
-
30
-
-
0033048502
-
1D receptor agonist
-
1D receptor agonist. J Med Chem (1999) 42:526-531.
-
(1999)
J Med Chem
, vol.42
, pp. 526-531
-
-
Xu, Y.C.1
Schaus, J.M.2
Walker, C.3
Krushinski, J.4
Adham, N.5
Zgombick, J.6
Liang, S.X.7
Kohlman, D.T.8
Audia, J.E.9
-
31
-
-
0033494873
-
-
1B/1D receptor agonists: Potential treatments for migraine. Med Chem Res (1999) 9:668-674.
-
(1999)
Med Chem Res
, vol.9
, pp. 668-674
-
-
-
32
-
-
0033494873
-
1B/1D receptor agonists: Potential treatments for migraine
-
1B/1D receptor agonists: Potential treatments for migraine. Med Chem Res (1999) 9:668-674.
-
(1999)
Med Chem Res
, vol.9
, pp. 668-674
-
-
Slassi, A.1
Meng, Q.C.2
Dyne, K.3
Wang, X.4
Lee, D.K.H.5
Kamboj, R.6
McCallum, K.L.7
Mazzocco, L.8
Rakhit, S.9
-
33
-
-
33747000514
-
1B/1D receptor agonists: Potential treatment for migraine
-
San Francisco:MEDI
-
1B/1D receptor agonists: Potential treatment for migraine. ACS (2000) 219 (San Francisco):MEDI 316.
-
(2000)
ACS
, vol.219
, pp. 316
-
-
Slassi, A.1
Meng, Q.C.2
Rakhit, S.3
Wang, X.4
Lee, D.K.H.5
Dyne, K.6
McCallum, K.L.7
Mazzocco, L.8
Kamboj, R.9
-
34
-
-
33747010586
-
1B/1D receptor agonists for the acute treatment of migraine
-
Boston:MED
-
1B/1D receptor agonists for the acute treatment of migraine. ACS (1998) 216 (Boston):MED1142.
-
(1998)
ACS
, vol.216
, pp. 1142
-
-
Ferez, M.1
Pallard, I.2
Fourrier, C.3
Potier, P.4
Pauwels, P.J.5
Palmer, C.6
Valentin, J.P.7
John, G.W.8
Halazy, S.9
-
35
-
-
0033006416
-
1B/1D receptors in models relevant to migraine
-
1B/1D receptors in models relevant to migraine. J Pharmacol Exp Ther (1999)290:83-95.
-
(1999)
J Pharmacol Exp Ther
, vol.290
, pp. 83-95
-
-
John, G.W.1
Pauwels, P.J.2
Ferez, M.3
Halazy, S.4
Le Grand, B.5
Verscheure, Y.6
Valentin, J.P.7
Palmier, C.8
Wurch, T.9
Chopin, P.10
Marien, M.11
Kleven, M.S.12
Koek, W.13
Assie, M.B.14
Carilla-Durand, E.15
Tarayre, J.P.16
Colpaert, F.C.17
-
36
-
-
0030663835
-
1B subtype
-
1B subtype. J Med Chem (1997) 40:3497-3500.
-
(1997)
J Med Chem
, vol.40
, pp. 3497-3500
-
-
Castro, J.L.1
Street, U.2
Guiblin, A.R.3
Jelley, R.A.4
Russell, M.G.N.5
Stemfeld, F.6
Beer, M.S.7
Stanton, J.A.8
Matassa, V.G.9
-
37
-
-
0033602128
-
1B subtype
-
1B subtype. J Med Chem (1999) 42:677-690.
-
(1999)
J Med Chem
, vol.42
, pp. 677-690
-
-
Stemfeld, F.1
Guiblin, A.R.2
Jelley, R.A.3
Matassa, V.G.4
Reeve, A.J.5
Hunt, P.A.6
Beer, M.S.7
Heald, A.8
Stanton, J.A.9
Sohal, B.10
Watt, A.P.11
Street, U.12
-
39
-
-
10744227604
-
Lsochroman-6-carboxamides as highly selective 5-HT, agonists: Potential new treatment for migraine without cardiovascular side effects
-
Ennis MD, Ghazal NB, Hoffman RL, Smith MW, Schlachter SK, Lawson CF, Im WB, Pregenzer JF, Svensson KA, Lewis RA, Hall ED, Sutler DM, Harris LT, McCall RB: lsochroman-6-carboxamides as highly selective 5-HT, agonists: potential new treatment for migraine without cardiovascular side effects. J Med Chem (1998) 41:2180-2183.
-
(1998)
J Med Chem
, vol.41
, pp. 2180-2183
-
-
Ennis, M.D.1
Ghazal, N.B.2
Hoffman, R.L.3
Smith, M.W.4
Schlachter, S.K.5
Lawson, C.F.6
Im, W.B.7
Pregenzer, J.F.8
Svensson, K.A.9
Lewis, R.A.10
Hall, E.D.11
Sutler, D.M.12
Harris, L.T.13
McCall, R.B.14
-
41
-
-
0032543298
-
1b/1D serotonin receptor ligands: A structure-affinity investigation
-
1b/1D serotonin receptor ligands: a structure-affinity investigation. J Med Chem (1998) 412243-2251.
-
(1998)
J Med Chem
, pp. 412243-412251
-
-
Law, H.1
Dukat, M.2
Teitler, M.3
Lee, D.K.H.4
Mazzocco, L.5
Kamboj, R.6
Rampersard, V.7
Prisinzano, T.8
Glennon, R.A.9
|